Home » Newsletters » BioWorld Asia

BioWorld Asia

July 26, 2000

View Archived Issues

Bone Marrow Could Yield Cells To Repopulate All Cell Types

French Start-Up Innate Pharma Raises $4.5M For Cancer Work

Compugen Plans IPO On Nasdaq Following $35M Private Financing

Ardana Spins Out OF MRC To Focus On Women's Health

EuropaBio, EPPOSI Meeting Focused On Rare Diseases

Vernalis' Migraine Treatment Cleared For French Market

EU Minister Remain Cautious About GMO Authorizations

G8 Leaders Take Supportive Stance On Biotechnology

Personal Chemistry Seeks $20M After Patent Questions Sink IPO

GPC, Cytovia Collaborate On Reverse Genomics, Cell Assays

Teva Strengthens European Ties With $135M Financing

Other News To Note

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 27, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Probing bidirectional cancer-autoimmune link can yield new targets
BioWorld Science
Cancer and autoimmunity are “often thought of as being at opposite ends of the immune response,” Ana Anderson told her audience at a joint meeting of the NIH’s...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.